Core Insights - Nutex Health Inc. reported a significant financial turnaround for the fiscal year 2024, with total revenue increasing by 93.8% to $479.9 million compared to $247.6 million in 2023, and net income of $52.1 million compared to a net loss of $45.8 million in the previous year [6][14][17] - The company restated its financial results for the fourth quarter and the entire fiscal year 2024, leading to a net increase in liabilities by $13.4 million (2.9%) and a corresponding decrease in equity by the same amount (6.6%) [4][3] - Adjusted EBITDA for 2024 reached $124.1 million, marking a 1046.1% increase from $10.8 million in 2023, indicating strong operational performance [6][11][22] Financial Performance - Total revenue for the year ended December 31, 2024, was $479.9 million, a 93.8% increase from $247.6 million in 2023 [6][14] - Net income attributable to Nutex Health for 2024 was $52.1 million, compared to a net loss of $45.8 million in 2023 [6][14] - Diluted earnings per share decreased by $0.02 to $9.69 from $9.71, while basic earnings per share also decreased by $0.02 to $10.23 from $10.25 [4][6] Operational Highlights - Total visits at the Hospital Division increased to 168,388 for the year ended December 31, 2024, up 16.9% from 144,058 in 2023 [14] - Revenue from mature hospitals (opened prior to December 31, 2021) increased by 56.6% in 2024 compared to 2023 [14] - Operating income for 2024 was $130.7 million, a significant improvement from an operating loss of $31.8 million in 2023 [14][17] Adjustments and Restatements - The restatement included non-cash adjustments, which had no material effect on key metrics such as revenue, liquidity, and operating cash flow [4][3] - Stock-based compensation expense for the year was $16.6 million, compared to $2.8 million in 2023, with 99% attributed to one-time obligations for under-construction hospitals [14][6] - The company corrected the classification of certain liabilities and reclassified related-party accounts payable balances, impacting the balance sheet structure [7][4] Cash Flow and Liquidity - Net cash from operating activities for the year was $23.2 million, reflecting improved operational efficiency [14][6] - As of December 31, 2024, the company had total assets of $655.3 million, including cash and cash equivalents of $40.6 million [15][14] - The company reported a record high cash balance of $40.6 million, underscoring its financial strength [11][14]

Core Insights - Nutex Health Inc. reported significant year-over-year growth in patient volume and cash collections for Q3 2025, indicating strong operational momentum and financial performance [1][8]. Financial Performance - Estimated patient volume for Q3 2025 increased to 46,293, representing an 11.1% growth compared to Q3 2024 [2]. - Cash collections for Q3 2025 reached $235,003, reflecting a substantial increase of 258.8% year-over-year [2]. - Year-to-date (YTD) patient volume for 2025 was 140,135, up 14.0% from 2024, while YTD cash collections totaled $546,003, marking a 176.9% increase [2]. Operational Highlights - The growth in patient volume was attributed to strategic facility expansion and increased demand for community-based acute care services [8]. - Enhanced revenue cycle management, improved payer mix, and higher patient acuity contributed to the surge in cash collections [8]. Compliance and Audit Progress - The company is actively working to meet Nasdaq's listing standards and has submitted a plan to regain compliance following a non-compliance notice due to errors in previously issued financial statements [6][7]. - Nutex Health anticipates filing its delinquent Form 10-Q for the period ended June 30, 2025, by December 12, 2025, as part of its compliance efforts [9].

Core Viewpoint - Nutex Health Inc. responds to allegations from a short seller report questioning its collection process, asserting that the claims are misleading and without merit [2][3]. Company Overview - Nutex Health Inc. is a physician-led integrated healthcare delivery system with 24 micro hospitals and hospital outpatient departments across 11 states, focusing on primary care and risk-bearing physician networks [1][4]. - The company was founded in 2011 and is headquartered in Houston, Texas, operating through two divisions: Hospital Division and Population Health Management Division [4][5]. Allegations and Response - The company is aware of a short seller report that challenges its medical claims collection process, which it believes misrepresents its business practices [2][3]. - Nutex Health has established a robust internal process for coding, billing, and submitting eligible medical claims, which includes a federally mandated negotiation period before independent dispute resolution [2]. Future Updates - The company plans to provide further updates regarding the allegations in its upcoming earnings release and Form 10-Q for the second quarter of 2025, expected by August 14, 2025 [3].

Core Viewpoint - Nutex Health Inc. will release its financial results for the first quarter ended March 31, 2025, on May 13, 2025, and will discuss these results in a conference call on May 14, 2025 [1] Company Overview - Nutex Health Inc. is headquartered in Houston, Texas, and was founded in 2011. It operates as a healthcare management and operations company with two main divisions: Hospital Division and Population Health Management Division [3] - The Hospital Division owns, develops, and operates innovative healthcare models, including 24 micro-hospitals across 11 states [3] - The Population Health Management Division manages provider networks such as Independent Physician Associations (IPAs) and offers management and administrative support services to affiliated hospitals and physician groups [4]